Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Opioid peptides, receptors, and immune function.

H N Bhargava1

  • 1Department of Pharmacodynamics, College of Pharmacy, University of Illinois, Chicago 60612.

NIDA Research Monograph
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of formulation parameters on the release characteristics of propranolol from asymmetric membrane coated tablets.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2007
Same author

Development and validation of a high-performance liquid chromatographic method for the analysis of propylthiouracil in pharmaceuticals.

Drug development and industrial pharmacy·2001
Same author

Synthesis and opiate receptor binding properties of 17-methyl-6,7-dehydro-3,14-dihydroxy-4,5alpha-epoxy-6,7:4',5'-pyrimidin omorphinans.

Bioorganic & medicinal chemistry letters·1999
Same author

Comparison of in vitro dissolution and permeation of fluconazole from different suppository bases.

Drug development and industrial pharmacy·1999
Same author

Sensitization to the locomotor stimulant effect of cocaine modifies the binding of [3H]MK-801 to brain regions and spinal cord of the mouse.

General pharmacology·1999
Same author

Enhancement of morphine antinociception by ibogaine and noribogaine in morphine-tolerant mice.

Pharmacology·1998

Methionine-enkephalin, an opioid peptide, stimulates immune function by activating T lymphocytes and enhancing natural killer cell activity. It shows potential therapeutic benefits for immunodeficient states like ARC and AIDS.

Area of Science:

  • Immunology
  • Neuroendocrinology
  • Molecular Biology

Background:

  • Opioid peptide binding sites are present on T lymphocytes.
  • Beta-endorphin is immunosuppressive, while methionine-enkephalin is immunostimulatory.
  • Methionine-enkephalin influences immune functions in vitro and in vivo.

Purpose of the Study:

  • To investigate the physiological role of methionine-enkephalin in the immune system.
  • To elucidate the mechanisms by which methionine-enkephalin activates T lymphocytes.
  • To explore the therapeutic potential of methionine-enkephalin in immunodeficient states.

Main Methods:

  • Studies involved in vitro and in vivo experiments.
  • Analysis of T lymphocyte activation via opioid receptors.

Related Experiment Videos

  • Assessment of intracellular signaling pathways and immune cell activity.

    • Main Results:

    • Methionine-enkephalin activates T lymphocytes, leading to the upregulation of IL-2, OKT10, and sheep T red blood cell receptors.
    • Enhanced natural killer cell activity and IL-2 production were observed.
    • Methionine-enkephalin promotes mitogen-induced lymphocyte proliferation.

    Conclusions:

    • Methionine-enkephalin plays a significant physiological role in immune modulation.
    • It activates T cells through opioid receptors, triggering downstream signaling cascades.
    • Methionine-enkephalin and related peptides show promise for treating immunodeficiencies, including ARC and AIDS.